Tranexamic acid in pediatric trauma: Why not?

Critical Care

Volumn 18, Issue 4, 2014, Pages

  Beno, Suzanne ^a   Ackery, Alun D ^b   Callum, Jeannie ^c   Rizoli, Sandro ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CHILDHOOD INJURY; HUMAN; MORTALITY; PEDIATRICS; PRIORITY JOURNAL; ADULT; CHILD; COMPARATIVE STUDY; COMPLICATION; HEMORRHAGE; HOSPITAL MORTALITY; INJURY; MULTICENTER STUDY (TOPIC); PERIOPERATIVE PERIOD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; SURVIVAL ANALYSIS;

ADULT; ANTIFIBRINOLYTIC AGENTS; CHILD; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MULTICENTER STUDIES AS TOPIC; PEDIATRICS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL ANALYSIS; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84903627004     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13965     Document Type: Article

References (40)

1. American Academy of Pediatrics, Pediatric Orthopedic Society of North America Policy statement: management of pediatric trauma. Pediatrics 2008, 121:849-854. American Academy of Pediatrics, Pediatric Orthopedic Society of North America.
2. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B. Clinical review: Canadian National Advisory Committee on Blood and Blood Products - massive Transfusion Consensus Conference 2011: report of the panel. Crit Care 2011, 15:242. 10.1186/cc10498, 3388668, 22188866.
3. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S, . CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010, 376:23-32. CRASH-2 trial collaborators.
4. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERS) study. Arch Surg 2012, 147:113-119. 10.1001/archsurg.2011.287, 22006852.
5. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme controlling medicines: introduction. Semin Thromb Hemost 1997, 23:493-501. 10.1055/s-2007-996127, 9469621.
6. Henry D, Carless P, Fergusson D, Laupacis A. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis. CMAJ 2009, 180:183-193. 10.1503/cmaj.081109, 2621296, 19050037.
7. Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123:687-696. 10.1016/j.thromres.2008.09.015, 19007970.
8. Naoulou B, Tsai MC. Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand 2012, 91:529-537. 10.1111/j.1600-0412.2012.01361.x, 22229782.
9. Gluud LL, Klingenberg SL, Langholz SE. Systematic review: tranexamic acid for upper gastrointestinal bleeding. Aliment Pharmacol Ther 2008, 27:752-758. 10.1111/j.1365-2036.2008.03638.x, 18248659.
10. Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De'Ath HD, Allard S, Hart DP, Pasi KJ, Hunt BJ, Stanworth S, MacCallum PK, Brohi K. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013, 11:307-314. 10.1111/jth.12078, 23176206.
11. Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T, . CRASH-2 trial collaborators The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011, 377:1096-1101. CRASH-2 trial collaborators.
12. Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg 2010, 110:350-353. 10.1213/ANE.0b013e3181c92b23, 19996135.
13. Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg 2012, 93:148-154. 10.1016/j.athoracsur.2011.07.085, 22054656.
14. Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth 2012, 59:6-13. 10.1007/s12630-011-9618-z, 22065333.
15. Koster A, Borgermann J, Zittermann A, Lueth JU, Gillis-Januszewski T, Schirmer U. Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: incidence and clinical outcome. Br J Anaesth 2012, 59:6-13.
16. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality. Prescrire Int 2013, 22:189-190.
17. Ross J, Salman RA. The frequency of thrombotic events among adults given antifibrinolytic drugs for spontaneous bleeding: systematic review and meta-analysis of observational studies and randomized trials. Curr Drug Saf 2012, 7:44-54. 10.2174/157488612800492744, 22663958.
18. Pretel IM, Marques ML, Aguado GL, Idoate Gastearena MA. Tranexamic acid-induced toxic epidermal necrolysis. Ann Pharmacother 2013, 47:e16. 10.1345/aph.1R637, 23447480.
19. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ 2012, 344:e3054. 10.1136/bmj.e3054, 3356857, 22611164.
20. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, Ker K. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011, 3:CD001886.
21. Faraoni D, Goobie SM. The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. Anesth Analg 2014, 118:628-636. 10.1213/ANE.0000000000000080, 24557107.
22. Ker K, Junko K, Perel P, Edwards P, Shakur H, Roberts I. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial. BMC Emerg Med 2012, 12:3. 10.1186/1471-227X-12-3, 3314558, 22380715.
23. Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Hansen DR, Hoots WK, Klein HG, Macdonald VW, Mattox KL, Michael RA, Mogford J, Montcalm-Smith EA, Niemeyer DM, Prusaczyk WK, Rappold JF, Rassmussen T, Rentas F, Ross J, Thompson C, Tucker LD, . US DoD Hemorrhage and Resuscitation Research and Development Steering Committee Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock 2013, 39:121-126. 10.1097/SHK.0b013e318280409a, 23222525, US DoD Hemorrhage and Resuscitation Research and Development Steering Committee.
24. Guerriero C, Cairns J, Perel P, Shakur H, Roberts I. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial. PLoS One 2011, 6:e18987. 10.1371/journal.pone.0018987, 3086904, 21559279.
25. Dewan Y, Komolafe EO, Mejia-Mantilla JH, Perel P, Roberts I, Shakur H, . CRASH-3 Collaborators CRASH-3-tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials 2012, 13:87. 10.1186/1745-6215-13-87, 3481366, 22721545, CRASH-3 Collaborators.
26. Basta MN, Stricker PA, Taylor JA. A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. Pediatr Surg Int 2012, 28:1059-1069. 10.1007/s00383-012-3167-6, 22940882.
27. McLeod LM, French B, Flynn JM, Dormans JP, Keren R. Antifibrinolytic use and blood transfusions in pediatric scoliosis surgeries performed at US children's hospitals. J Spinal Disord Tech 2013, [Epub ahead of print].
28. Grassin-Delyle S, Couturier R, Abe E, Alvarez JC, Devillier P, Urien S. A practical tranexamic acid dosing scheme based on population pharmacokinetics in children undergoing cardiac surgery. Anesthesiology 2013, 118:853-862. 10.1097/ALN.0b013e318283c83a, 23343649.
29. Albiani DA, Hodge WG, Pan YI, Urton TE, Clarke WN. Tranexamic acid in the treatment of pediatric traumatic hyphema. Can J Opthalmol 2008, 43:428-431.
30. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006, 60:S3-S11. 10.1097/01.ta.0000199961.02677.19, 16763478.
31. Mitra B, Cameron PA, Mori A, Fitzgerald M. Acute coagulopathy and early deaths post major trauma. Injury 2012, 43:22-25. 10.1016/j.injury.2010.10.015, 21145056.
32. Talving P, Lustenberger T, Lam L, Inaba K, Mohseni S, Plurad D, Green DJ, Demetriades D. Coagulopathy after isolated severe traumatic brain injury in children. J Trauma 2011, 71:1205-1210. 10.1097/TA.0b013e31820d151d, 21427617.
33. Peiniger S, Nienaber U, Lefering R, Braun M, Wafaisade A, Borgman MA, Spinella PC, Maegele M, . Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie Glasgow Coma Scale as a predictor for hemocoagulative disorders after blunt pediatric traumatic brain injury. Pediatr Crit Care Med 2012, 13:455-460. 10.1097/PCC.0b013e31823893c5, 22422166, Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie.
34. Whittaker BW, Christiaans SC, Altice JL, Chen MK, Bartolucci AA, Morgan CJ, Kerby JD, Pittet JF. Early coagulopathy is an independent predictor of mortality in children after severe trauma. Shock 2013, 39:421-426. 10.1097/SHK.0b013e31828e08cb, 3689548, 23591559.
35. Holmes JF, Goodwin HC, Land C, Kuppermann N. Coagulation testing in pediatric blunt trauma patients. Pediatr Emerg Care 2001, 17:324-328. 10.1097/00006565-200110000-00002, 11673707.
36. Hendrickson JE, Shaz BH, Pereira G, Atkins E, Johnson KK, Bao G, Easley KA, Josephson CD. Coagulopathy is prevalent and associated with adverse outcomes in transfused pediatric trauma patients. J Pediatr 2012, 160:204-209. 10.1016/j.jpeds.2011.08.019, 21925679.
37. Patregnani JT, Borgman MA, Maegele M, Wade CE, Blackbourne LH, Spinella PC. Coagulopathy and shock on admission is associated with mortality for children with traumatic injuries at combat support hospitals. Pediatr Crit Care Med 2012, 13:273-277. 10.1097/PCC.0b013e31822f1727, 21926654.
38. Vogel AM, Radwin ZA, Cox CS, Cotton BA. Admission rapid thrombelastography delivers real-time 'actionable' data in pediatric trauma. J Ped Surg 2013, 48:1371-1376.
39. Royal College of Paediatrics and Child Health Evidence statement. Major trauma and the use of tranexamic acid in children. November 2012 http://www.rcpch.ac.uk/system/files/protected/page/121112_TXA%20evidence%20statement_final%20v2.pdf, Royal College of Paediatrics and Child Health.
40. Harvey V, Perrone J, Kim P. Does the use of tranexamic acid improve trauma mortality?. Ann Emerg Med 2013, pii:S0196-0644(13)01341-3.